<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33556114</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>CVB3 VP1 interacts with MAT1 to inhibit cell proliferation by interfering with Cdk-activating kinase complex activity in CVB3-induced acute pancreatitis.</ArticleTitle><Pagination><StartPage>e1008992</StartPage><MedlinePgn>e1008992</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1008992</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1008992</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) belongs to the genus Enterovirus of the family Picornaviridae and can cause acute acinar pancreatitis in adults. However, the molecular mechanisms of pathogenesis underlying CVB3-induced acute pancreatitis have remained unclear. In this study, we discovered that CVB3 capsid protein VP1 inhibited pancreatic cell proliferation and exerted strong cytopathic effects on HPAC cells. Through yeast two-hybrid, co-immunoprecipitation, and confocal microscopy, we show that Menage a trois 1 (MAT1), a subunit of the Cdk-Activating Kinase (CAK) complex involved in cell proliferation and transcription, is a novel interaction protein with CVB3 VP1. Moreover, CVB3 VP1 inhibited MAT1 accumulation and localization, thus interfering with its interaction with CDK7. Furthermore, CVB3 VP1 could suppress CAK complex enzymic phosphorylation activity towards RNA Pol II and CDK4/6, direct substrates of CAK. VP1 also suppresses phosphorylation of retinoblastoma protein (pRb), an indirect CAK substrate, especially at phospho-pRb Ser780 and phospho-pRb Ser807/811 residues, which are associated with cell proliferation. Finally, we present evidence using deletion mutants that the C-terminal domain (VP1-D8, 768-859aa) is the minimal VP1 region required for its interaction with MAT1, and furthermore, VP1-D8 alone was sufficient to arrest cells in G1/S phase as observed during CVB3 infection. Taken together, we demonstrate that CVB3 VP1 can inhibit CAK complex assembly and activity through direct interaction with MAT1, to block MAT1-mediated CAK-CDK4/6-Rb signaling, and ultimately suppress cell proliferation in pancreatic cells. These findings substantially extend our basic understanding of CVB3-mediated pancreatitis, providing strong candidates for strategic therapeutic targeting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongxia</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5574-8284</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Lingbing</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7073-0039</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-8950-6133</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Guilin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Affiliated Hospital of JiangXi university of TCM, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jieyu</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4625-3359</Identifier><AffiliationInfo><Affiliation>Fuzhou Medical School of Nanchang University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zengbin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-0237-4458</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yilian</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7377-458X</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Huizhen</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5928-6355</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5988-833X</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Qiaofa</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-0399-2346</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xiaotian</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-1145-8386</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C514215">MNAT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000627674">VP1 protein, enterovirus B</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="D018844">Cyclin-Dependent Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="D000095043">Cyclin-Dependent Kinase-Activating Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059447" MajorTopicYN="N">Cell Cycle Checkpoints</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="Y">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018844" MajorTopicYN="N">Cyclin-Dependent Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010195" MajorTopicYN="N">Pancreatitis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095043" MajorTopicYN="N">Cyclin-Dependent Kinase-Activating Kinase</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they do not have any conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>8</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33556114</ArticleId><ArticleId IdType="pmc">PMC7895353</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1008992</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-20-02049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tao Z, Song Y, Li Y, Liu Y, Jiang P, Lin X, et al. Coxsackievirus B3, Shandong Province, China, 1990-2010. Emerg Infect Dis. 2012;18(11):1865&#x2013;7. 10.3201/eid1811.120090 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1811.120090</ArticleId><ArticleId IdType="pmc">PMC3559141</ArticleId><ArticleId IdType="pubmed">23092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol. 2012;24(4):401&#x2013;7. 10.1097/BOR.0b013e328353372d .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328353372d</ArticleId><ArticleId IdType="pmc">PMC4536812</ArticleId><ArticleId IdType="pubmed">22488075</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun SH, Lee WG, Kim YC, Ju ES, Lim BK, Choi JO, et al. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. J Infect Dis. 2012;205(3):491&#x2013;7. 10.1093/infdis/jir745</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir745</ArticleId><ArticleId IdType="pubmed">22207647</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R, McMahon MJ. Acute pancreatitis and serological evidence of infection with Mycoplasma pneumoniae. Gut. 1978;19(5):367&#x2013;70. 10.1136/gut.19.5.367</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.19.5.367</ArticleId><ArticleId IdType="pmc">PMC1412106</ArticleId><ArticleId IdType="pubmed">658765</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattre P, et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol. 2000;74(21):10153&#x2013;64. 10.1128/jvi.74.21.10153-10164.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.21.10153-10164.2000</ArticleId><ArticleId IdType="pmc">PMC102054</ArticleId><ArticleId IdType="pubmed">11024144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AH, Lau CS, Cheng PK, Ng AY, Lim WW. Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong. J Med Virol. 2011;83(3):483&#x2013;9. 10.1002/jmv.21998</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21998</ArticleId><ArticleId IdType="pubmed">21264869</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S, Ramsingh AI. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004;17(3):358&#x2013;69. 10.1089/vim.2004.17.358</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.358</ArticleId><ArticleId IdType="pubmed">15357902</ArticleId></ArticleIdList></Reference><Reference><Citation>Haarmann CM, Schwimmbeck PL, Mertens T, Schultheiss HP, Strauer BE. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology. 1994;200(2):381&#x2013;9. 10.1006/viro.1994.1202</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1202</ArticleId><ArticleId IdType="pubmed">7513917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N, Gangaplara A, Arumugam R, Massilamany C, Pokal S, Zhou Y, et al. Identification of Immunogenic Epitopes That Permit the Detection of Antigen-Specific T Cell Responses in Multiple Serotypes of Group B Coxsackievirus Infections. Viruses. 2020;12(3):347 10.3390/v12030347</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12030347</ArticleId><ArticleId IdType="pmc">PMC7150766</ArticleId><ArticleId IdType="pubmed">32245257</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X, Lu Q, Hu J, Xiong S. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route. Microb Cell Fact. 2019;18(1):66 10.1186/s12934-019-1115-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-019-1115-z</ArticleId><ArticleId IdType="pmc">PMC6449988</ArticleId><ArticleId IdType="pubmed">30947747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye T, Yue Y, Fan X, Dong C, Xu W, Xiong S. M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine. Vaccine. 2014;32(35):4457&#x2013;65. 10.1016/j.vaccine.2014.06.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.06.050</ArticleId><ArticleId IdType="pubmed">24958702</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Zhang L, Organtini LJ, Hafenstein S, Bergelson JM. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment. J Virol. 2015;89(2):1324&#x2013;8. 10.1128/JVI.02798-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02798-14</ArticleId><ArticleId IdType="pmc">PMC4300647</ArticleId><ArticleId IdType="pubmed">25392210</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoder JD, Cifuente JO, Pan J, Bergelson JM, Hafenstein S. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface. J Virol. 2012;86(23):12571&#x2013;81. 10.1128/JVI.01592-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01592-12</ArticleId><ArticleId IdType="pmc">PMC3497627</ArticleId><ArticleId IdType="pubmed">22973031</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Xia Y, Huang S, Liu F, Ying Y, Xu Q, et al. Identification of the interaction of VP1 with GM130 which may implicate in the pathogenesis of CVB3-induced acute pancreatitis. Sci Rep. 2015;5:13324 10.1038/srep13324</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13324</ArticleId><ArticleId IdType="pmc">PMC4551966</ArticleId><ArticleId IdType="pubmed">26314804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisteau X, Paternot S, Colleoni B, Ecker K, Coulonval K, De Groote P, et al. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point. PLoS Genet. 2013;9(5):e1003546 10.1371/journal.pgen.1003546</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003546</ArticleId><ArticleId IdType="pmc">PMC3667761</ArticleId><ArticleId IdType="pubmed">23737759</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervais V, Lamour V, Jawhari A, Frindel F, Wasielewski E, Dubaele S, et al. TFIIH contains a PH domain involved in DNA nucleotide excision repair. Nat Struct Mol Biol. 2004;11(7):616&#x2013;22. 10.1038/nsmb782</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb782</ArticleId><ArticleId IdType="pubmed">15195146</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilbach S, Hantsche M, Tegunov D, Dienemann C, Wigge C, Urlaub H, et al. Structures of transcription pre-initiation complex with TFIIH and Mediator. Nature. 2017;551(7679):204&#x2013;9. 10.1038/nature24282</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24282</ArticleId><ArticleId IdType="pmc">PMC6078178</ArticleId><ArticleId IdType="pubmed">29088706</ArticleId></ArticleIdList></Reference><Reference><Citation>Gileadi O, Busso D, Keriel A, Sandrock B, Poterszman A, Egly JM. Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activities. J Biol Chem. 2000;275(30):22815&#x2013;23. 10.1074/jbc.M002578200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002578200</ArticleId><ArticleId IdType="pubmed">10801852</ArticleId></ArticleIdList></Reference><Reference><Citation>Compe E, Genes CM, Braun C, Coin F, Egly JM. TFIIE orchestrates the recruitment of the TFIIH kinase module at promoter before release during transcription. Nat Commun. 2019;10(1):2084 10.1038/s41467-019-10131-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10131-1</ArticleId><ArticleId IdType="pmc">PMC6504876</ArticleId><ArticleId IdType="pubmed">31064989</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirode F, Busso D, Coin F, Egly JM. Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7. Mol Cell. 1999;3(1):87&#x2013;95. 10.1016/s1097-2765(00)80177-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1097-2765(00)80177-x</ArticleId><ArticleId IdType="pubmed">10024882</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher RP. Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery. Transcription. 2019;10(2):47&#x2013;56. 10.1080/21541264.2018.1553483</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541264.2018.1553483</ArticleId><ArticleId IdType="pmc">PMC6602562</ArticleId><ArticleId IdType="pubmed">30488763</ArticleId></ArticleIdList></Reference><Reference><Citation>Larochelle S, Chen J, Knights R, Pandur J, Morcillo P, Erdjument-Bromage H, et al. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. EMBO J. 2001;20(14):3749&#x2013;59. 10.1093/emboj/20.14.3749</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.14.3749</ArticleId><ArticleId IdType="pmc">PMC125544</ArticleId><ArticleId IdType="pubmed">11447116</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthet C, Kaldis P. Cdk2 and Cdk4 cooperatively control the expression of Cdc2. Cell Div. 2006;1:10 10.1186/1747-1028-1-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1747-1028-1-10</ArticleId><ArticleId IdType="pmc">PMC1524953</ArticleId><ArticleId IdType="pubmed">16759374</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley B, Thomas M, McFarlane C, Gilmour S, Sharma M, Kambadur R. Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway. Oncogene. 2004;23(2):524&#x2013;34. 10.1038/sj.onc.1207144</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1207144</ArticleId><ArticleId IdType="pubmed">14724580</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M, Liu C, Yang HW, Koberlin MS, Cappell SD, Meyer T. Transient Hysteresis in CDK4/6 Activity Underlies Passage of the Restriction Point in G1. Mol Cell. 2019;76(4):562&#x2013;73,e4. 10.1016/j.molcel.2019.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.08.020</ArticleId><ArticleId IdType="pmc">PMC7189330</ArticleId><ArticleId IdType="pubmed">31543423</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudsen ES, Wang JY. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol. 1997;17(10):5771&#x2013;83. 10.1128/mcb.17.10.5771</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.17.10.5771</ArticleId><ArticleId IdType="pmc">PMC232425</ArticleId><ArticleId IdType="pubmed">9315635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuda NJ, Ardehali MB, Lis JT. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature. 2009;461(7261):186&#x2013;92. 10.1038/nature08449</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08449</ArticleId><ArticleId IdType="pmc">PMC2833331</ArticleId><ArticleId IdType="pubmed">19741698</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlen KM, Churchman LS. The code and beyond: transcription regulation by the RNA polymerase II carboxy-terminal domain. Nat Rev Mol Cell Biol. 2017;18(4):263&#x2013;73. 10.1038/nrm.2017.10 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.10</ArticleId><ArticleId IdType="pubmed">28248323</ArticleId></ArticleIdList></Reference><Reference><Citation>Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet. 2012;13(10):720&#x2013;31. 10.1038/nrg3293</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3293</ArticleId><ArticleId IdType="pmc">PMC3552498</ArticleId><ArticleId IdType="pubmed">22986266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirackal Manavalan AP, Pilarova K, Kluge M, Bartholomeeusen K, Rajecky M, Oppelt J, et al. CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes. EMBO Rep. 2019;20(9):e47592 10.15252/embr.201847592</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201847592</ArticleId><ArticleId IdType="pmc">PMC6727028</ArticleId><ArticleId IdType="pubmed">31347271</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu HC, Huang WR, Liao TL, Chi PI, Nielsen BL, Liu JH, et al. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction. J Biol Chem. 2018;293(32):12542&#x2013;62. 10.1074/jbc.RA118.002341</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.002341</ArticleId><ArticleId IdType="pmc">PMC6093226</ArticleId><ArticleId IdType="pubmed">29907572</ArticleId></ArticleIdList></Reference><Reference><Citation>Caffarelli N, Fehr AR, Yu D. Cyclin A degradation by primate cytomegalovirus protein pUL21a counters its innate restriction of virus replication. PLoS Pathog. 2013;9(12):e1003825 10.1371/journal.ppat.1003825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003825</ArticleId><ArticleId IdType="pmc">PMC3873445</ArticleId><ArticleId IdType="pubmed">24385906</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice AP. Cyclin-dependent kinases as therapeutic targets for HIV-1 infection. Expert Opin Ther Targets. 2016;20(12):1453&#x2013;61. 10.1080/14728222.2016.1254619</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2016.1254619</ArticleId><ArticleId IdType="pmc">PMC5219930</ArticleId><ArticleId IdType="pubmed">27797603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice AP. Roles of CDKs in RNA polymerase II transcription of the HIV-1 genome. Transcription. 2019;10(2):111&#x2013;7. 10.1080/21541264.2018.1542254</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541264.2018.1542254</ArticleId><ArticleId IdType="pmc">PMC6602559</ArticleId><ArticleId IdType="pubmed">30375919</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H, Abduljabbar R, Lai CF, Periyasamy M, Harrod A, Gemma C, et al. Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer. Clin Cancer Res. 2016;22(23):5929&#x2013;38. 10.1158/1078-0432.CCR-15-1104</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-15-1104</ArticleId><ArticleId IdType="pmc">PMC5293170</ArticleId><ArticleId IdType="pubmed">27301701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chlamydas S, Holz H, Samata M, Chelmicki T, Georgiev P, Pelechano V, et al. Functional interplay between MSL1 and CDK7 controls RNA polymerase II Ser5 phosphorylation. Nat Struct Mol Biol. 2016;23(6):580&#x2013;9. 10.1038/nsmb.3233</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3233</ArticleId><ArticleId IdType="pubmed">27183194</ArticleId></ArticleIdList></Reference><Reference><Citation>Glover-Cutter K, Larochelle S, Erickson B, Zhang C, Shokat K, Fisher RP, et al. TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II. Mol Cell Biol. 2009;29(20):5455&#x2013;64. 10.1128/MCB.00637-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00637-09</ArticleId><ArticleId IdType="pmc">PMC2756882</ArticleId><ArticleId IdType="pubmed">19667075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang R, Li Y, Sun Y, Song C, Zhan Y, et al. Newcastle disease virus induces G0/G1 cell cycle arrest in asynchronously growing cells. Virology. 2018;520:67&#x2013;74. 10.1016/j.virol.2018.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2018.05.005</ArticleId><ArticleId IdType="pmc">PMC7112094</ArticleId><ArticleId IdType="pubmed">29793075</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2. J Virol. 2018;92(18):e00663&#x2013;18. 10.1128/JVI.00663-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00663-18</ArticleId><ArticleId IdType="pmc">PMC6146702</ArticleId><ArticleId IdType="pubmed">29997218</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan ST, Karges W, Cooper CL, Crawley AM. Hepatitis C virus core protein reduces CD8(+) T-cell proliferation, perforin production and degranulation but increases STAT5 activation. Immunology. 2018;154(1):156&#x2013;65. 10.1111/imm.12882</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12882</ArticleId><ArticleId IdType="pmc">PMC5904700</ArticleId><ArticleId IdType="pubmed">29266204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan RP, Hensley LL, Evers LE, Lemon SM, McGivern DR. Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis. J Virol. 2011;85(16):7989&#x2013;8001. 10.1128/JVI.00280-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00280-11</ArticleId><ArticleId IdType="pmc">PMC3147967</ArticleId><ArticleId IdType="pubmed">21680513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 1993;73(3):487&#x2013;97. 10.1016/0092-8674(93)90136-e</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90136-e</ArticleId><ArticleId IdType="pubmed">8343202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter T, Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell. 1994;79(4):573&#x2013;82. 10.1016/0092-8674(94)90543-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(94)90543-6</ArticleId><ArticleId IdType="pubmed">7954824</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimel JK, Taatjes DJ. The essential and multifunctional TFIIH complex. Protein Sci. 2018;27(6):1018&#x2013;37. 10.1002/pro.3424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3424</ArticleId><ArticleId IdType="pmc">PMC5980561</ArticleId><ArticleId IdType="pubmed">29664212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Leone GW, Wang H. Cyclin D-CDK4/6 functions in cancer. Adv Cancer Res. 2020;148:147&#x2013;69. 10.1016/bs.acr.2020.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.acr.2020.02.002</ArticleId><ArticleId IdType="pubmed">32723562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval J, Pereda J, Rodriguez JL, Escobar J, Hidalgo J, Joosten LA, et al. Ordered transcriptional factor recruitment and epigenetic regulation of tnf-alpha in necrotizing acute pancreatitis. Cell Mol Life Sci. 2010;67(10):1687&#x2013;97. 10.1007/s00018-010-0272-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-010-0272-3</ArticleId><ArticleId IdType="pmc">PMC11115704</ArticleId><ArticleId IdType="pubmed">20130956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada L, Nagano Y, Hasegawa A, Kanai H, Nogami K, Ito S, et al. IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. PLoS Pathog. 2017;13(9):e1006597 10.1371/journal.ppat.1006597</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006597</ArticleId><ArticleId IdType="pmc">PMC5614654</ArticleId><ArticleId IdType="pubmed">28910419</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang ML, Wang CT, Yang SJ, Leu CH, Chen SH, Wu CL, et al. IL-6 ameliorates acute lung injury in influenza virus infection. Sci Rep. 2017;7:43829 10.1038/srep43829</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43829</ArticleId><ArticleId IdType="pmc">PMC5338329</ArticleId><ArticleId IdType="pubmed">28262742</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol. 1995;69(11):6720&#x2013;8. 10.1128/JVI.69.11.6720-6728.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.11.6720-6728.1995</ArticleId><ArticleId IdType="pmc">PMC189582</ArticleId><ArticleId IdType="pubmed">7474082</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007;2(5):1236&#x2013;47. 10.1038/nprot.2007.135</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.135</ArticleId><ArticleId IdType="pubmed">17546019</ArticleId></ArticleIdList></Reference><Reference><Citation>He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998;95(5):2509&#x2013;14. 10.1073/pnas.95.5.2509</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.5.2509</ArticleId><ArticleId IdType="pmc">PMC19394</ArticleId><ArticleId IdType="pubmed">9482916</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>